Maroun Badr il 15/05/2025

Endocrine consequences of childhood obesity: a narrative review

Front Endocrinol (Lausanne). 2025 Apr 30;16:1584861. doi: 10.3389/fendo.2025.1584861. eCollection 2025.ABSTRACTChildhood obesity has emerged as a significant public health challenge, with profound consequences that negatively impact endocrine functions. Excess adiposity in children leads to dysregul

Lingfeng Zhang il 14/05/2025

Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization

BMC Psychiatry. 2025 May 14;25(1):484. doi: 10.1186/s12888-025-06914-0.ABSTRACTBACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have recently received Food and Drug Administration (FDA) approval for obesity management. However, the causal relationship between GLP-1RAs and psychiatric